Microscale syntheses of anti-tumour platinum compounds labelled with 191Pt.
Several compounds of platinum have been found to have significant anti-tumour activity and are in various stages of clinical trials. Four such compounds: cis-PtCl2(NH3)2, cis PtCl2(cyclopropylamine)2, cis,trans-PtCl2(OH)2(isopropylamine)2 and cis-Pt(1,1-cyclobutanedicarboxylate) (NH3)2 were synthesised with radioactive platinum-191 as a label for the study of animal organ distribution, patient blood clearance, urinary excretion and renal uptake and clearance. This paper describes the microscale synthesis of these compounds. Purification and quality control procedures are also described.
D000970:Antineoplastic Agents / Q000138:chemical synthesis*; D016190:Carboplatin; D002945:Cisplatin / Q000138:chemical synthesis; D007553:Isotope Labeling / Q000379:methods; D009944:Organoplatinum Compounds / Q000138:chemical synthesis*; D010984:Platinum; D011868:Radioisotopes
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D011868:Radioisotopes; C036146:dichlorobis(cyclopropylamine)platinum II; D010984:Platinum; C023359:iproplatin; D016190:Carboplatin; D002945:Cisplatin